Peter D. Kies

2020

In 2020, Peter D. Kies earned a total compensation of $2.2M as Chief Financial Officer at Inovio Pharmaceuticals, a 88% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$198,260
Salary$445,639
Stock Awards$1,499,996
Other$10,010
Total$2,153,905

Kies received $1.5M in stock awards, accounting for 70% of the total pay in 2020.

Kies also received $198.3K in non-equity incentive plan, $445.6K in salary and $10K in other compensation.

Rankings

In 2020, Peter D. Kies' compensation ranked 5,193rd out of 13,090 executives tracked by ExecPay. In other words, Kies earned more than 60.3% of executives.

ClassificationRankingPercentile
All
5,193
out of 13,090
60th
Division
Manufacturing
2,134
out of 5,621
62nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
260
out of 799
68th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
143
out of 495
71st
Industry
Surgical and Medical Instruments and Apparatus
92
out of 313
71st

Pay ratio

Peter D. Kies' Pay$2,153,905
Median Employee's Pay$185,948
Pay Ratio

12

to 1

In 2020, the annual total compensation of Peter D. Kies was $2,153,905.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $185,948.

The ratio of Peter D. Kies' pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on March 25, 2021.

Kies' colleagues

We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2020.

2020

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2020

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

2020

Jacqueline Shea

Inovio Pharmaceuticals

Chief Operating Officer

News

You may also like